China Pharma Holdings Number of Employees 2010-2025 | CPHI

China Pharma Holdings number of employees from 2010 to 2025. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
China Pharma Holdings Annual Employee Count
2024 231
2023 239
2022 244
2021 246
2020 248
2019 242
2018 252
2017 296
2016 385
2015 415
2014 439
2013 443
2012 443
2011 435
2010 410
2009 294
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.007B $0.005B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.207B 6.94
Dr Reddy's Laboratories (RDY) India $12.054B 21.88
BridgeBio Pharma (BBIO) United States $6.426B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.872B 15.19
Bausch Health Cos (BHC) Canada $1.692B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.181B 7.87
Taysha Gene Therapies (TSHA) United States $0.580B 0.00
Personalis (PSNL) United States $0.437B 0.00
Assembly Biosciences (ASMB) United States $0.103B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00